UT Southwestern biochemist is honoured for breakthrough metabolic research

UT Southwestern Biochemist Benjamin Tu, Ph.D., is the recipient of the 2021 Edith and Peter O'Donnell Award in Science from TAMEST (The Academy of Medicine, Engineering and Science of Texas). He was chosen for his pioneering research on cellular roles of small molecule metabolites that may have relevance for cancer treatments and other diseases.

Dr. Tu's approach to studying yeast to reveal conserved behavior in mammalian cells has led to the discovery of a unique pathway supporting the survival and growth of cancerous cells. By understanding how the pathway works in the mammalian cells, Dr. Tu was able to block the nutrient pathway feeding cancerous cell growth.

His revolutionary work challenges the long-held belief that metabolites are merely passive in their function. Instead, Dr. Tu's research unveils that metabolites may drive key cellular processes and suggests the importance and influence of the metabolic state on cell regulation.

"Dr. Tu is like a detective - he is really excellent at figuring out the nuts and bolts of how cells work, how they function, and how they are regulated," said Margaret Phillips, Ph.D., Professor and Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry at UT Southwestern Medical Center. "The regulation of growth is important in cells because if growth is allowed to proceed in an unregulated fashion, it can lead to cancer or other diseases. What makes Dr. Tu so amazing is he has just made one important discovery after another in multiple different areas of metabolism throughout his career. He is a brilliant scientist."

Dr. Tu, UT Southwestern Presidential Scholar and a W.W. Caruth, Jr. Scholar in Biomedical Research, is one of four Texas-based scientists receiving the TAMEST 2021 Edith and Peter O'Donnell Awards for their individual contributions addressing the essential role that science and technology play in society, and whose work meets the highest standards of exemplary professional performance, creativity and resourcefulness.

We believe Dr. Tu's research will lead to future therapeutic advancements for diseases. As a pioneer in his field, we are honored to recognize him as the recipient of our 2021 O'Donnell Award in Science and are grateful for the discoveries he is making here in Texas that will impact the rest of the world."

David E. Daniel, Ph.D. (NAE), 2021 Board President, TAMEST

Dr. Tu will be recognized at the 2021 O'Donnell Awards virtual ceremony on Wednesday, January 13 at 4 p.m. CT and will give a subsequent virtual talk on his groundbreaking research on February 24, 2021, at 11 a.m. CT.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
You might also like... ×
Genes inherited from parents are responsible for severe COVID-19